Literature DB >> 8625565

Shoulder instability in athletes. The Asian perspective.

K M Chan1, N Maffulli, M Nobuhara, J J Wu.   

Abstract

Recently, there has been an upsurge of interest among the orthopaedic sports medicine community in Asia on this subject of athletic shoulder instability. This is particularly prominent in countries such as Japan, Korea, Taiwan, and Hong Kong, where sports requiring throwing and overhead use of the upper limb are popular. In this review, the classification of the condition is analyzed with a specific account of the rotator interval injury. A systematic plan of clinical assessment is presented highlighting the specific regional considerations in clinical practice and cost-effectiveness of the health care systems in Asia. The management of athletic shoulder instability depends on patient attitude and cultural background. In Asia, the popular choice of Bankart repair with capsular shift procedure is presented with special reference to the unique experience of multidirectional and habitual posterior instability. Arthroscopic surgery is becoming popular in Asia, and the indications and limitations of the technique in the management of shoulder instability are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8625565     DOI: 10.1097/00003086-199602000-00014

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  Objective assessment of shoulder mobility with a new 3D gyroscope--a validation study.

Authors:  Bilal Farouk El-Zayat; Turgay Efe; Annett Heidrich; Udo Wolf; Nina Timmesfeld; Thomas J Heyse; Stefan Lakemeier; Susanne Fuchs-Winkelmann; Markus D Schofer
Journal:  BMC Musculoskelet Disord       Date:  2011-07-21       Impact factor: 2.362

2.  Objective assessment, repeatability, and agreement of shoulder ROM with a 3D gyroscope.

Authors:  Bilal Farouk El-Zayat; Turgay Efe; Annett Heidrich; Robert Anetsmann; Nina Timmesfeld; Susanne Fuchs-Winkelmann; Markus Dietmar Schofer
Journal:  BMC Musculoskelet Disord       Date:  2013-02-26       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.